Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyProphylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy.
P2860
Q24186359-DA289C5F-1F7F-4138-86D8-B6FF69AD4D8EQ24186913-56A68863-EC36-45DA-A3BA-2C678EF41395Q24187751-CEAEBF4F-8B37-47D2-9BE2-28EEC9C788FEQ24198288-274C3FE9-608D-4A92-B0E8-318AD70D38EDQ24198774-C84021BD-B5D2-4A18-BEFD-693A874EE0FDQ24198795-5589CBB6-EC40-4D2A-A818-DDB1EFBC6184Q24198832-4B244BBE-66B2-4462-AADC-86B551853658Q30248355-A7CAF598-D13F-40CB-AEFE-39B3631ABB60Q33436425-DA76AC9E-9147-4484-8EE0-FEDA8127CE2CQ48076529-352349E0-2196-4867-B650-6A25B63B396CQ48273685-1E1194F1-1E7A-4133-8468-B1BFD384C90C
P2860
Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Does bleeding affect patient-r ...... gnancies: a systematic review.
@ast
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en-gb
type
label
Does bleeding affect patient-r ...... gnancies: a systematic review.
@ast
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en-gb
prefLabel
Does bleeding affect patient-r ...... gnancies: a systematic review.
@ast
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en-gb
P2093
P2860
P50
P356
P1433
P1476
Does bleeding affect patient-r ...... gnancies: a systematic review.
@en
P2093
Anne M Kelly
Deborah Pinchon
Emily Symington
Simon Stanworth
Susan Brunskill
P2860
P304
P356
10.1111/TRF.12441
P577
2013-10-10T00:00:00Z